Skip to main content
Log in

Characterization of T cell clones specific to a determinant of hepatitis B virus core and e antigens in chronic type B hepatitis: Implication for a T cell mechanism of HBV immunopathogenesis

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

T cell clones specific for hepatitis B core (HBcAg) and e (HBeAg) antigens of hepatitis B virus (HBV) were generated from liver infiltrates of HBeAg-positive patients. Analyzed with a panel of overlapping synthetic peptides spanning the complete sequences of HBcAg and HBeAg, eight clones responded specifically to the e2 peptide (PAYRPPNAPIL; amino acid residues 130–140 of HBcAg and HBeAg), which was doubly restricted by class I and II molecules. A preferential usage of the T cell receptor (TCR) α chain variable (Vα) gene was found: Vα12.1 for five HLA-Cw9(3)-restricted cytotoxic T lymphocyte (CTL) clones, and Vα7.1 for three other HLA-DRw52-restricted type 1 helper T cell (Th1) clones. Although heterogeneous in the usage of TCR α chain joining region (Jα) segments, their junctional-region sequences revealed conserved hydrophilic serine residues in seven of the eight e2-specific T cell clones. Single alanine substitution of the centrally located and the only hydrophilic asparagine residue of e2 peptide abrogated T cell responsiveness. The nonstimulatory e2 analogue could competitively inhibit e2-specific responses. These results demonstrate that both CTL and Th1 clones recognizing a determinant of HBcAg and HBeAg are present in the liver of chronic hepatitis B patients. The preferential Vα gene usage and the expression of conserved residues in junctional-region sequences of TCRα chains by viral-peptide-specific, intrahepatic T cells may provide a T cell mechanism of HBV immunopathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adorini L, Nagy ZA. Peptide competition for antigen presentation. Immunol Today 11:21–24;1990.

    Article  PubMed  Google Scholar 

  2. Argos P, Fuller SD. A model for the hepatitis B virus core protein: Prediction of antigenic sites and relationship to RNA virus capsid proteins. EMBO J 7:819–824;1989.

    Google Scholar 

  3. Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F. Recognition of hepatitis B virus envelope proteins by liver infiltrating T lymphocytes in chronic HBV infection. J Immunol 143:2650–2655;1989.

    PubMed  Google Scholar 

  4. Barnaba V, Franco A, Alberti A, Benvenuto R, Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature 345:258–260;1990.

    Article  PubMed  Google Scholar 

  5. Beasley RP, Hwang LY, Lin CC, Chien CC. Hepatocellular carcinoma and hepatitis B virus. Lancet ii:1129–1133;1981.

    Article  Google Scholar 

  6. Benner KG, Lee RG, Keeffe EB, Lopez RR, Sasaki AW, Pinson CW. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology 103:1307–1312;1992.

    PubMed  Google Scholar 

  7. Bertoletti A, Chisari FV, Penna A, Galati L, Cavalli A, Missale G, Fowler P, Fiaccadori F, Ferrari C. The optimal epitope recognized by HLA-A2 restricted cytotoxic T cells is defined by 10 amino acid sequence of the hepatitis B virus (HBV) nucleoprotein. 8th International Congress of Immunology, Budapest, Hungary, Aug 23–28, 1992, W-55, No 3 (abstract).

  8. Blue ML, Daley JF, Levine H, Craig KA, Schlossman SF. Biosynthesis and surface expression of T8 by peripheral blood T4+ cells in vitro. J Immunol 137:1202–1207;1986.

    PubMed  Google Scholar 

  9. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 (suppl 97):77–89;1968.

    PubMed  Google Scholar 

  10. Carreno BM, Turner RV, Biddison WE, Coligan JE. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. J Immunol 148:894–899;1992.

    PubMed  Google Scholar 

  11. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda K, Ishak KG, eds. Neoplasms of the liver. Tokyo, Springer, 71–80;1987.

    Google Scholar 

  12. Chen DS. From hepatitis to hepatoma: Lessons learned from type B hepatitis. Science 262:369–370;1993.

    PubMed  Google Scholar 

  13. Chen HL, Chiu TS, Chen PJ, Chen DS. Cytogenetic studies on human liver cancer cell lines. Cancer Genet Cytogenet 65:161–166;1993.

    Article  PubMed  Google Scholar 

  14. Chen PJ, Chen CR, Sung JL, Chen DS. Identification of a doubly spliced viral transcript joining the separated domains for putative protease and reverse transcriptase of hepatitis B virus. J Virol 63:4165–4171;1989.

    PubMed  Google Scholar 

  15. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764–768;1992.

    Article  PubMed  Google Scholar 

  16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159;1987.

    Article  PubMed  Google Scholar 

  17. Chu CM, Liaw YF. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection: Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology 92:220–225;1987.

    PubMed  Google Scholar 

  18. Chu CM, Shyu WC, Kuo RW, Liaw YF. HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis. Hepatology 7:1311–1316;1987.

    Google Scholar 

  19. Colucci G, Beazer Y, Cantaluppi C, Tackney C. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies. J Immunol 141:4376–4380;1988.

    PubMed  Google Scholar 

  20. Davies TF, Martin A, Concepcion ES, Graves P, Cohen L, Ben-Nun A. Evidence of limited variability of antigen receptors on intra-thyroidal T cells in autoimmune thyroid disease. N Engl J Med 325:238–244;1991.

    PubMed  Google Scholar 

  21. DeLisi C, Berzofsky J. T cell antigenic sites tend to be amphipathic structures. Proc Natl Acad Sci USA 82:7048–7052;1985.

    PubMed  Google Scholar 

  22. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S. Purified protein derivative ofMycobacterium tuberculosis and excretory-secretory antigen(s) ofToxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88:346–350;1991.

    PubMed  Google Scholar 

  23. DerSimonian H, Band H, Brenner MB. Increased frequency of T cell receptor Vα12.1 expression on CD8+ T cells: Evidence that Vα participates in shaping the peripheral T cell repertoire. J Exp Med 174:639–648;1991.

    Article  PubMed  Google Scholar 

  24. Doherty PC, Allen W, Eichelberger M, Carding SR. Roles of αβ and γδ T cell subsets in viral immunity. Annu Rev Immunol 10:123–151;1992.

    PubMed  Google Scholar 

  25. Duke RC. Self recognition by T cell. 1: By-stander killing of target cells bearing syngeneic MHC antigens. J Exp Med 170:59–71;1989.

    Article  PubMed  Google Scholar 

  26. Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codons 84–101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J CLin Invest 89:332–338;1992.

    PubMed  Google Scholar 

  27. Falk K, Rötzschke O, Rammensee HG. Specificity of antigen processing for MHC class I-restricted presentation is conserved between mouse and man. Eur J Immunol 22:1323–1326;1992.

    PubMed  Google Scholar 

  28. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, Pilli M, Fowler P, Giuberti T, Chisari FV, Fiaccadori F. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 88:214–222;1991.

    PubMed  Google Scholar 

  29. Ferrari C, Mondelli MU, Penna A, Fiaccadori F, Chisari FV. Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 139:539–544;1987.

    PubMed  Google Scholar 

  30. Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 139:2059–2065;1987.

    PubMed  Google Scholar 

  31. Guilhot S, Fowler P, Portillo G, Margolskee RF, Ferrari C, Bertoletti A, Chisari FV. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: Production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines. J Virol 66:2670–2678;1992.

    PubMed  Google Scholar 

  32. Hahn YS, Hahn CS, Braciale VL, Braciale TJ, Rice CM. CD8+ T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J Exp Med 176:1335–1341;1992.

    Article  PubMed  Google Scholar 

  33. Hoffmann RM, Pape GR, Rieber P, Eisenburg J, Döhrmann J, Zachoval R, Paumgartner G, Riethmüller G. Cytolytic T cell clones derived from liver tissue of patients with chronic hepatitis B. Eur J Immunol 16:1635–1638;1986.

    PubMed  Google Scholar 

  34. Hsu HC, Su IJ, Lai MY, Chen DS, Chang MH, Chuang SM, Sung JL. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection. J Hepatol 5:45–50;1987.

    Article  PubMed  Google Scholar 

  35. Jorgensen JL, Esser U, Groth BF, Reay PA, Davis MM. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224–230;1992.

    Article  PubMed  Google Scholar 

  36. Jorgensen JL, Reay PA, Ehrich EW, Davis MM. Molecular components of T-cell recognition. Annu Rev Immunol 10:836–873;1992.

    Article  Google Scholar 

  37. Kamogawa Y, Yamauchi K, Obata H, Chisaka O, Matsubara K, Hepatitis B virus-DNA transfected myeloma cell-specific cytotoxic T cells in chronic hepatitis B patients. Virology 191:321–326;1992.

    Article  PubMed  Google Scholar 

  38. Kaye J, Kersh G, Engel I, Hedrick SM. Structure and specificity of the T cell antigen receptor. Semin Immunol 3:269–281;1991.

    PubMed  Google Scholar 

  39. Klein MH, Concannon P, Everett M, Kim LDH, Hunkapiller T, Hood L. Diversity and structure of human T-cell receptor α-chain variable region genes. Proc Natl Acad Sci USA 84:6884–6888;1987.

    PubMed  Google Scholar 

  40. Kropshofer H, Max H, Müller CA, Hesse F, Stevanovic S, Jung G, Kalbacher H. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med 175:1799–1803;1992.

    Article  PubMed  Google Scholar 

  41. Lee CJ, Lee PC, Tai JJ, Lee PH. Human leucocyte antigens in inhabitants of Taiwan. J Formosan Med Assoc 89:526–533;1990.

    PubMed  Google Scholar 

  42. Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DJ, Chang-Chien CS. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology 84:216–219;1983.

    PubMed  Google Scholar 

  43. Maeji NJ, Bray AM, Geysen HM. Multi-pin peptide synthesis strategy for T cell determinant analysis. J Immunol Methods 134:23–33;1990.

    Article  PubMed  Google Scholar 

  44. Maruyama T, McLachlan A, Iino S, Koike K, Kurokawa K, Milich DR. The serology of chronic hepatitis B infection revisited. J Clin Invest 91:2586–2595;1993.

    PubMed  Google Scholar 

  45. Merrifield RB. Solid phase synthesis. Science 232:341–347;1986.

    PubMed  Google Scholar 

  46. Milich DR, Hughes JL, McLachlan A, Thornton GB, Moriarty A. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc Natl Acad Sci USA 85:1610–1614;1988.

    PubMed  Google Scholar 

  47. Milich DR, McLachlan A, Moriarty A, Thornton GB. Immune response to hepatitis B virus core antigen (HBcAg): Localization of T cell recognition sites within HBcAg/HBeAg. J Immunol 139:1223–1231;1987.

    PubMed  Google Scholar 

  48. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, Ferrari C, Chiasir FV. HLA-A31- and HLA-Aw68-restricted T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177:751–762;1993.

    Article  PubMed  Google Scholar 

  49. Moretta A, Pantaleo G, Moretta L, Cerottini JC, Mingari MC. Direct demonstration of the clonogenic potential of every human peripheral blood T cell: Clonal analysis of HLA-DR expression and cytolytic activity. J Exp Med 157:743–754;1983.

    Article  PubMed  Google Scholar 

  50. Mutch DA, Rodda SJ, Benstead M, Valerio RM, Geysen HM. Effects of end groups on the stimulatory capacity of minimal length T cell determinant peptides. Pept Res 4:132–137;1991.

    PubMed  Google Scholar 

  51. Nalefski EA, Kasibhatla S, Rao A. Functional analysis of the antigen binding site on the T cell receptor α chain. J Exp Med 175:1553–1563;1992.

    Article  PubMed  Google Scholar 

  52. Newcomb JR, Cresswell P. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J Immunol 150:449–507;1993.

    Google Scholar 

  53. Oksenberg JR, Stuart S, Begovich AB, Bell RB, Erlich HA, Steinman L, Bernard CCA. Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients. Nature 345:344–346;1990.

    Article  PubMed  Google Scholar 

  54. Peters M, Vierling J, Gershwin ME, Milich DR, Chisari FV, Hoofnagle JH. Immunology and liver. Hepatology 13:977–994;1991.

    Article  PubMed  Google Scholar 

  55. Rammensee HG, Falk K, Rötzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213–244;1993.

    Article  PubMed  Google Scholar 

  56. Roman-Roman S, Ferradini L, Azocar J, Genevée C, Hercend T, Triebel F. Studies on the human T cell receptor α/β variable region genes. I: Identification of 7 additional Vα subfamilies and 14 Jα gene segments. Eur J Immunol 21:927–933;1991.

    PubMed  Google Scholar 

  57. Salfeld J, Pfaff E, Noah M, Schaller H. Antigenic determinants and functional domains in core antigen and e antigens from hepatitis B virus. J Virol 63:798–808;1989.

    PubMed  Google Scholar 

  58. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467;1977.

    PubMed  Google Scholar 

  59. Sharrock CEM; Kaminski E, Man S. Limiting dilution analysis of human T cells: A useful clinical tool. Immunol Today 11:281–285;1990.

    Article  PubMed  Google Scholar 

  60. Standring DN, Ou JH, Masiarz FR, Rutter WJ. A signal peptide endoced within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens inXenopus ooxytes. Proc Natl Acad Sci USA 85:8405–8409;1988.

    PubMed  Google Scholar 

  61. Tabor S, Richardson CC. DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proc Natl Acad Sci USA 84:4767–4771;1987.

    PubMed  Google Scholar 

  62. Takahashi H, Germain RN, Moss B, Berzofsky JA. An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself. J Exp Med 171:571–576;1990.

    Article  PubMed  Google Scholar 

  63. Townsend ARM, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959–968;1986.

    Article  PubMed  Google Scholar 

  64. Toyonaga B, Mak TW. Genes of the T-cell antigen receptor in normal and malignant T cells. Annu Rev Immunol 5:585–620;1987.

    Article  PubMed  Google Scholar 

  65. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, Hwang LH, Chang TH, Chen DS. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens: Implications for hepatitis B e antigen seroconversion. J Clin Invest 89:87–96;1992.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tsai, SL., Chen, PJ., Yang, PM. et al. Characterization of T cell clones specific to a determinant of hepatitis B virus core and e antigens in chronic type B hepatitis: Implication for a T cell mechanism of HBV immunopathogenesis. J Biomed Sci 1, 105–118 (1994). https://doi.org/10.1007/BF02257984

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02257984

Key Words

Navigation